Veracyte, Inc.

Biotech valuations and funding availability went into reverse in the second half of 2021, following a period of abundant financing. Meanwhile, big pharma companies face their own problems, with many b

It seems almost every company presenting at this year’s J.P. Morgan Healthcare Conference in San Fransisco has been hard at work in recent weeks, crafting press releases and fine-tuning their news flo

Eikon Therapeutics, Inc. came out of stealth mode with an icon at its helm last year and a venture capital mega-round to fund development of a technology platform that uses super-resolution microscop

Veracyte is continuing to aggressively build its cancer diagnostics business with an agreement to acquire HalioDx for €147m ($180m) in cash and up to €113m ($138m) in stock, the companies announced o